Literature DB >> 23681498

A comprehensive multimodal pain treatment reduces opioid consumption after multilevel spine surgery.

Ole Mathiesen1, Benny Dahl, Berit A Thomsen, Birgitte Kitter, Nan Sonne, Jørgen B Dahl, Henrik Kehlet.   

Abstract

PURPOSE: Major spine surgery with multilevel instrumentation is followed by large amount of opioid consumption, significant pain and difficult mobilization in a population of predominantly chronic pain patients. This case-control study investigated if a standardized comprehensive pain and postoperative nausea and vomiting (PONV) treatment protocol would improve pain treatment in this population.
METHODS: A new regimen with acetaminophen, NSAIDs, gabapentin, S-ketamine, dexamethasone, ondansetron and epidural local anesthetic infusion or patient controlled analgesia with morphine, was introduced in a post-intervention group of 41 consecutive patients undergoing multilevel (median 10) instrumented spinal fusions and compared with 44 patients in a pre-intervention group.
RESULTS: Compared to patients in the pre-intervention group, patients treated according to the new protocol consumed less opioid on postoperative day (POD) 1 (P = 0.024) and 2 (P = 0.048), they were mobilized earlier from bed (P = 0.003) and ambulation was earlier both with and without a walking frame (P = 0.027 and P = 0.027, respectively). Finally, patients following the new protocol experienced low intensities of nausea, sedation and dizziness on POD 1-6.
CONCLUSIONS: In this study of patients scheduled for multilevel spine surgery, it was demonstrated that compared to a historic group of patients receiving usual care, a comprehensive and standardized multimodal pain and PONV protocol significantly reduced opioid consumption, improved postoperative mobilization and presented concomitant low levels of nausea, sedation and dizziness.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23681498      PMCID: PMC3777071          DOI: 10.1007/s00586-013-2826-1

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  25 in total

1.  Postoperative opioid sparing to hasten recovery: what are the issues?

Authors:  Henrik Kehlet
Journal:  Anesthesiology       Date:  2005-06       Impact factor: 7.892

2.  National in-hospital morbidity and mortality trends after lumbar fusion surgery between 1998 and 2008.

Authors:  M Pumberger; Y-L Chiu; Y Ma; F P Girardi; M Mazumdar; S G Memtsoudis
Journal:  J Bone Joint Surg Br       Date:  2012-03

3.  Sample sizes for studies using the short form 36 (SF-36)

Authors:  S A Julious; S George; M J Campbell
Journal:  J Epidemiol Community Health       Date:  1995-12       Impact factor: 3.710

Review 4.  The value of "multimodal" or "balanced analgesia" in postoperative pain treatment.

Authors:  H Kehlet; J B Dahl
Journal:  Anesth Analg       Date:  1993-11       Impact factor: 5.108

5.  A prospective, randomized, multicenter Food and Drug Administration investigational device exemptions study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: part I: evaluation of clinical outcomes.

Authors:  Scott Blumenthal; Paul C McAfee; Richard D Guyer; Stephen H Hochschuler; Fred H Geisler; Richard T Holt; Rolando Garcia; John J Regan; Donna D Ohnmeiss
Journal:  Spine (Phila Pa 1976)       Date:  2005-07-15       Impact factor: 3.468

6.  Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease.

Authors:  Jack Zigler; Rick Delamarter; Jeffrey M Spivak; Raymond J Linovitz; Guy O Danielson; Thomas T Haider; Frank Cammisa; Jim Zuchermann; Richard Balderston; Scott Kitchel; Kevin Foley; Robert Watkins; David Bradford; James Yue; Hansen Yuan; Harry Herkowitz; Doug Geiger; John Bendo; Timothy Peppers; Barton Sachs; Federico Girardi; Michael Kropf; Jeff Goldstein
Journal:  Spine (Phila Pa 1976)       Date:  2007-05-15       Impact factor: 3.468

7.  Postoperative ketorolac does not predispose to pseudoarthrosis following posterior spinal fusion and instrumentation for adolescent idiopathic scoliosis.

Authors:  Daniel J Sucato; John F Lovejoy; Sundeep Agrawal; Emily Elerson; Trudi Nelson; Anna McClung
Journal:  Spine (Phila Pa 1976)       Date:  2008-05-01       Impact factor: 3.468

8.  Predictors of length of stay and patient satisfaction after hip and knee replacement surgery: fast-track experience in 712 patients.

Authors:  Henrik Husted; Gitte Holm; Steffen Jacobsen
Journal:  Acta Orthop       Date:  2008-04       Impact factor: 3.717

9.  Peridural methylprednisolone and wound infiltration with bupivacaine for postoperative pain control after posterior lumbar spine surgery: a randomized double-blinded placebo-controlled trial.

Authors:  Kitti Jirarattanaphochai; Surachai Jung; Somboon Thienthong; Wimonrat Krisanaprakornkit; Chat Sumananont
Journal:  Spine (Phila Pa 1976)       Date:  2007-03-15       Impact factor: 3.468

Review 10.  Effects of nonsteroidal anti-inflammatory drugs on bone formation and soft-tissue healing.

Authors:  Laurence E Dahners; Brian H Mullis
Journal:  J Am Acad Orthop Surg       Date:  2004 May-Jun       Impact factor: 3.020

View more
  54 in total

1.  Excess Opioid Medication and Variation in Prescribing Patterns Following Common Orthopaedic Procedures.

Authors:  Matthew J Sabatino; Samuel T Kunkel; Dipak B Ramkumar; Benjamin J Keeney; David S Jevsevar
Journal:  J Bone Joint Surg Am       Date:  2018-02-07       Impact factor: 5.284

2.  Continuous wound infusion of ropivacaine for the control of pain after thoracolumbar spinal surgery: a randomized clinical trial.

Authors:  Bo Xu; Li Ren; Weifeng Tu; Zenghui Wu; Fuzhi Ai; Dongxu Zhou; Biyun Chen; Xingan Zhang
Journal:  Eur Spine J       Date:  2015-05-03       Impact factor: 3.134

3.  Preoperative pregabalin has no effect on intraoperative neurophysiological monitoring in adolescents undergoing posterior spinal fusion for spinal deformities: a double-blind, randomized, placebo-controlled clinical trial.

Authors:  Linda Helenius; Antti Puhakka; Tuula Manner; Olli Pajulo; Ilkka Helenius
Journal:  Eur Spine J       Date:  2017-11-17       Impact factor: 3.134

4.  Lumbar Spine Surgeries and Medication Usage During Hospital Stay: One-Center Perspective.

Authors:  Neena K Sharma; Busuyi Olotu; Asha Mathew; Lemuel R Waitman; Rafia Rasu
Journal:  Hosp Pharm       Date:  2017-11-09

5.  Intravenous Acetaminophen Reduces Length of Stay Via Mediation of Postoperative Opioid Consumption After Posterior Spinal Fusion in a Pediatric Cohort.

Authors:  Vanessa A Olbrecht; Lili Ding; Kristie Spruance; Monir Hossain; Senthilkumar Sadhasivam; Vidya Chidambaran
Journal:  Clin J Pain       Date:  2018-07       Impact factor: 3.442

Review 6.  Analgesic therapy for major spine surgery.

Authors:  Varun Puvanesarajah; Jason A Liauw; Sheng-fu Lo; Ioan A Lina; Timothy F Witham; Allan Gottschalk
Journal:  Neurosurg Rev       Date:  2015-02-14       Impact factor: 3.042

7.  Incidence and Risk Factors for Chronic Postoperative Opioid Use After Major Spine Surgery: A Cross-Sectional Study With Longitudinal Outcome.

Authors:  Lauren K Dunn; Sandeep Yerra; Shenghao Fang; Mark F Hanak; Maren K Leibowitz; Siny Tsang; Marcel E Durieux; Edward C Nemergut; Bhiken I Naik
Journal:  Anesth Analg       Date:  2018-07       Impact factor: 5.108

8.  Effect of ketamine on transcranial motor-evoked potentials during spinal surgery: a pilot study.

Authors:  Stephanie Lam; Masanori Nagata; Sonia K Sandhu; Robert A Veselis; Patrick J McCormick
Journal:  Br J Anaesth       Date:  2019-10-07       Impact factor: 9.166

Review 9.  Multimodal analgesia in pain management after spine surgery.

Authors:  Joon S Yoo; Junyoung Ahn; Asokumar Buvanendran; Kern Singh
Journal:  J Spine Surg       Date:  2019-09

10.  Cost-effectiveness of intravenous acetaminophen and ketorolac in adolescents undergoing idiopathic scoliosis surgery.

Authors:  Vidya Chidambaran; Rajeev Subramanyam; Lili Ding; Senthilkumar Sadhasivam; Kristie Geisler; Bobbie Stubbeman; Peter Sturm; Viral Jain; Mark H Eckman
Journal:  Paediatr Anaesth       Date:  2018-01-29       Impact factor: 2.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.